Alzheimer’s Disease and dementia were taught by 17 Schools althou

Alzheimer’s Disease and dementia were taught by 17 Schools although just 10 and eight Schools respectively covered them in detail. ADHD, autism, eating disorders,

OCD, and personality disorder received little attention and were poorly covered by the majority of Schools. Teaching centred on pharmacology and therapeutics with very few Schools covering social aspects of mental health disorders. Six Schools had taken a deliberate decision to concentrate teaching on those conditions which students were most likely to see in practice. Two selleck chemicals llc Schools had a mental health option in the curriculum. Experiential opportunities for students were limited: six Schools offered some sort of placement but not all involved patient contact; and just four Schools used expert patients in classroom teaching.

Eight Schools employed at least one full-time academic member of staff that had previously worked as a mental health pharmacist. In the other 11 Schools, five employed, on a sessional basis, practising mental health pharmacists to deliver aspects of the undergraduate provision; the remaining six Schools relied heavily on hospital teacher practitioners, regardless of background, to teach mental health disorders. Only three Schools had any teaching input from other healthcare professionals. Current teaching of mental health in Schools shows that subject areas that are more prevalent in society GKT137831 cost are majored on but less commonly encountered conditions are less well covered. This ‘strategic’ approach to those conditions commonly met in practice seems reasonable given the challenges Schools face when determining MPharm curriculum content. Delivery was primarily ‘classroom’ based, taught by pharmacists, and which was medicines centric with very little attention given over to wider determinants Fenbendazole of mental health. This theory-based uni-professional view of mental health disorders raises questions about how well prepared students are to provide mental health services. 1. Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain

in Europe 2010. European Neuropsychopharmacology 2011; 21: 655–679. 2. Brandford D. Survey shows wide variations in the teaching of psychiatric pharmacy. Pharm J 1990; 245: 591. Sara McMillan1, Adem Sav1, Fiona Kelly4,2, Michelle King4, Jennifer Whitty3, Amanda Wheeler1,2 1Griffith Health Institute, Griffith University, QLD, Australia, 2Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand, 3Griffith Health Institute, Griffith University, QLD, Australia, 4Griffith University, QLD, Australia To explore determinants influencing pharmacy choice for Australian residents with chronic health conditions and unpaid carers. The provision of patient-centred care, such as a caring relationship, continuity of care and individualised counselling, were important determinants for people when choosing a pharmacy.

Comments are closed.